BISAX
Price
$25.56
Change
-$0.38 (-1.46%)
Updated
Nov 13 closing price
Net Assets
1.35B
MOWNX
Price
$21.92
Change
-$0.12 (-0.54%)
Updated
Nov 13 closing price
Net Assets
232.6M
Interact to see
Advertisement

BISAX vs MOWNX

Header iconBISAX vs MOWNX Comparison
Open Charts BISAX vs MOWNXBanner chart's image
Brandes International Small Cap Equity A
Price$25.56
Change-$0.38 (-1.46%)
VolumeN/A
Net Assets1.35B
Moerus Worldwide Value N
Price$21.92
Change-$0.12 (-0.54%)
VolumeN/A
Net Assets232.6M
BISAX vs MOWNX Comparison Chart in %
View a ticker or compare two or three
VS
BISAX vs. MOWNX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BISAX is a Hold and MOWNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BISAX has more cash in the bank: 1.35B vs. MOWNX (233M). MOWNX pays higher dividends than BISAX: MOWNX (3.04) vs BISAX (2.69). BISAX was incepted earlier than MOWNX: BISAX (14 years) vs MOWNX (9 years). MOWNX (1.81) is less costly to investors than BISAX (1.32). MOWNX is a more actively managed with annual turnover of: 46.00 vs. BISAX (16.60). BISAX (2500) and MOWNX (2500) have matching initial minimum investment requirements. BISAX annual gain was more profitable for investors over the last year : 42.92 vs. MOWNX (35.69). BISAX return over 5 years is better than : 197.21 vs. MOWNX (179.75).
BISAXMOWNXBISAX / MOWNX
Total Expense Ratio1.321.5187%
Annual Report Gross Expense Ratio1.321.8173%
Fund Existence14 years9 years-
Gain YTD42.49035.631119%
Front Load6%N/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.35B233M580%
Annual Yield % from dividends2.693.0489%
Returns for 1 year42.9235.69120%
Returns for 3 years155.9198.10159%
Returns for 5 years197.21179.75110%
Returns for 10 years153.77N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYTOF0.100.01
+7.53%
Altamira Therapeutics Ltd.
RKLIF5.08N/A
N/A
Rentokil Initial Plc
SHVTF3.35N/A
N/A
Select Harvests Ltd.
HLPMF9.00N/A
N/A
HELLENiQ ENERGY Holdings SA
DTCFF0.59N/A
-0.15%
DEFENCE THERAPEUTICS INC